Oral tranexamic acid (TA) has been an effective treatment for melasma with unclear mechanism.
ObjectiveThe present study aimed to demonstrate the effect of TA on melanogenesis via regulation of TGF-β1 expression in keratinocytes.
MethodsWe firstly determined the expression level of TGF-β1 in TA-treated keratinocyte-conditioned medium (KCM). Then the mRNA and protein levels of microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), and tyrosinase-related protein-1 (TRP-1) of human epidermal melanocytes (NHEMs) in presence of TA-treated KCM were evaluated via RT-PCR and Western blot analysis. Moreover, melanin content and tyrosinase activity were quantified. TGF-β1 gene was knocked down by small interfering RNA (siRNA) in keratinocytes.
ResultsThe mRNA and protein levels of TGF-β1 in keratinocytes were significantly increased after TA treatment. Melanin contents, tyrosinase activity, protein and mRNA levels of TYR, MITF, and TRP-1 were downregulated in NHEMs in the presence of TA-treated KCM. Knockdown of TGF-β1 in keratinocytes could attenuate the inhibitory effect of TA-treated KCM on melanogenesis.
ConclusionTA could stimulate TGF-β1 expression in keratinocytes, which further inhibits melanogenesis through the paracrine signaling.
Comments (0)